is gas a side effect of semaglutide effects for diabetes and obesity treatment Ozempic (semaglutide) is a GLP-1

Childhood obesity rates have skyrocketed over 300% since the 1970s, now affecting 21% of children

telehealth and medically integrated programs

d-Chiro-inositol is a natural molecule that, in association with its well-studied isomer myo-inositol, may play a role in treating various metabolic and gynecological disorders

Siete datos sobre este nueva droga inyectable y la opinin de los profesionales de salud sobre su efectividad.

Intra EAA+ Lean muscle support

Integration of obesity medicine into gastroenterology training programs and metabolic clinics may further redefine the future scope of GI practice.Modern gastroenterology is undergoing a transition toward obesity-focused and metabolic care